Background. Whilst dopexamine appears to increase overall splanchnic blood¯ow in postoperative and septic patients, the effects on gastric mucosal perfusion are controversial and based on concomitantly increasing mucosal to arterial PCO 2 gradients (PdCO 2 ). We hypothesized that dopexamine alters splanchnic blood¯ow distribution and metabolism during experimental endotoxin shock and modi®es the in¯ammatory response induced by endotoxin.
Inotropic drugs are frequently required in sepsis to increase systemic blood¯ow and oxygen delivery. Poor splanchnic perfusion may accompany sepsis, and therefore inotropes with preferential splanchnic vasodilation may be of use. Dopexamine is a widely used inotrope in the UK. 1 It may improve splanchnic perfusion although controversial results exist in the literature. 2±4 In addition to its circulatory effects, dopexamine may also attenuate in¯ammatory responses in sepsis. 5 Subacute experimental endotoxaemia is a well-accepted model of sepsis. 6±8 The primary response to endotoxin infusion is an abrupt increase in pulmonary vascular resistance followed by a decrease in cardiac function. 6 8 During the progression of endotoxin shock a hyperdynamic, hypotensive circulation with a systemic in¯ammatory response develops.
Based on our preliminary results, 9 we hypothesized that dopexamine alters blood¯ow distribution and metabolism within the splanchnic region during experimental endotoxin shock and modi®es the in¯ammatory response to endotoxin. We aimed to study the haemodynamic and metabolic effects of dopexamine in an experimental model of subacute (prolonged to 14 h) endotoxaemia. In particular, we focusedstudied the effects of dopexamine on blood¯ow distribution and metabolism later during the progression of sepsis. Finally, we investigated the effects of dopexamine on markers of in¯ammation.
Materials and methods
The institutional animal use and care committee of the University of Kuopio approved this study procedure.
Anaesthesia
Twenty-one Finnish landrace pigs (24±35 kg) were fasted for 48 h with access to water. The gastrointestinal tract was emptied with an osmotic laxative (Colonsteril â , Orion, Espoo, Finland) 2 days before the experiment. Thirty minutes before preparation, the animals were premedicated with atropine 0.05 mg kg ±1 of body weight and azaperone 8 mg kg ±1 i.m. An ear vein was cannulated and anaesthesia was induced with i.v. ketamine (250 mg) and sodium thiopental 5±15 mg kg ±1 . Anaesthesia was maintained with sodium thiopental (5±10 mg kg ±1 h ±1 ) and fentanyl (5 mg kg ±1 h ±1 ) infusions. Animals were weighed and moved to the operating table. We used tracheotomy to ensure secure airway access. The lungs were ventilated with volumecontrolled mode ventilator (Servo 900E, Siemens Elema, Sweden). The partial pressure of arterial blood oxygen was maintained above 13.3 kPa by adjusting the fraction of oxygen in the inspiratory gas (FI O 2 ). Tidal volume was maintained within 10±15 ml kg ±1 and minute volume adjusted to maintain normocapnoea 4.5±5.5 kPa (34± 41 mm Hg). Positive end-expiratory pressure of 5 cm H 2 O was used throughout the experiment. We measured pulmonary artery occlusion pressure (PAOP) every hour during the experiment and maintained this between 5±7 mm Hg aiming to normovolaemia. Core temperature was measured using the thermistor at the tip of the pulmonary artery catheter and was maintained between 38 and 39°C by regulating the temperature of the table, i.v.¯uids and using a heat lamp. We used 2±4 mg i.v. injections of pancuronium (Pavulon â NV Organon, Oss, Netherlands) for neuromuscular block.
Fluid management
For maintenance¯uid therapy, saline 5 ml kg ±1 h ±1 , 0.9% was infused throughout the experiment. Fluid resuscitation with Ringer's acetate and hydroxyethyl starch 1:1 was given to achieve PAOP 5±7 mm Hg at baseline. During the different phases of endotoxaemia, volume challenges (20± 50 ml) were given if cardiac output or systemic arterial pressure decreased abruptly or systemic arterial pressure in response to the respiratory cycle occurred. 10 However, PAOP was maintained <10±12 and CVP <16 mm Hg, because¯uid resuscitation was limited by right ventricular function. Glucose 50% infusion was used to maintain blood glucose at 5±7 mmol litre ±1 .
Animal preparation
Full sterility was maintained throughout the surgery. We cannulated the right femoral artery to measure systemic arterial blood pressure and to collect arterial blood samples. Right jugular and subclavian veins were prepared. The hepatic vein was cannulated through the jugular vein and the location of the catheter was ensured with manual palpation and ultrasound as required. A pulmonary artery catheter was directed to the pulmonary artery through the right subclavian vein. A full midline laparotomy was performed. The urinary bladder was drained, a nasogastric tube was inserted, and the stomach emptied. We used calibrated perivascular ultrasonic transit time¯ow probes (Transonic Systems Inc., Ithaca, NY, USA). The descending aorta was visualized through the diaphragm and¯ow probe inserted (14 mm) around the aorta. We inserted a left pleural drain and closed the diaphragm. Portal, coeliac trunk, superior mesenteric artery and hepatic arteries were visualized and correct sized probes inserted (12, 6, 6 , and 4 mm, respectively). Care was taken to visualize all (1±3) branches of the hepatic artery. Colonic, mesenteric, gastric and portal veins were cannulated to collect regional blood samples. The vessels were cannulated using Seldinger's technique and ®xed only to the entry site of the cannula in the vessel wall and therefore the cannulae did not occlude the vessels. The vein draining the great curve of stomach is a`double' vein with abundant anastomoses between the two so that the venous out¯ow from the great curve was not occluded by cannulating one of the vessels. Tonometers (Tonometrics, Datex/instrumentarium, Helsinki, Finland) with microdialysis capillaries were inserted into the colon and jejunum. We guided the tip of the tonometer 10±15 cm inside the lumen of the gut through a small anti-mesenteric incision, which was then carefully sutured. The gastric tonometer was guided into the stomach orally and its position was veri®ed by manual palpation. We closed the laparotomy in two layers and ®nally inserted a right pleural drain. At the end of the experiment the animals were killed with i.v. injection of magnesium sulphate while still anaesthetized.
Experimental procedure
All animals were allowed to stabilize for 8±10 h. A block randomization in three clusters was applied using closed opaque envelopes. We randomly allocated the animals into three groups: ETX (n=7) with Escherichia coli endotoxin infusion, DOPE (n=7) with E. coli endotoxin and dopexamine infusion and controls (n=7). Initially we collected the baseline samples, and if randomized into a group 1±2, started the E. coli endotoxin infusion (20 mg ml ±1 in glucose 5%) at a rate of 0.5 mg kg ±1 h ±1 . After 2±4 h, the infusion rate was increased stepwise (doubled every 45±60 min) to induce systemic hypotension. Incremental dosage of endotoxin was limited by not allowing the mean pulmonary arterial pressure to exceed 40 mm Hg. Dopexamine infusion was started after the pulmonary hypertension occurred and was followed by an abrupt decrease in cardiac output. We aimed to increase cardiac output to baseline or higher and adjusted dopexamine infusion accordingly. When cardiac output exceeded baseline, dopexamine infusion was continued at a ®xed rate until the end of the experiment.
Tonometry
Gastric, jejunal and colonic mucosal partial pressure of carbon dioxide was measured with a semiautomatic gas analyser (Tonocap â , Datex-Ohmeda, Helsinki, Finland) every 10 min throughout the experiment. Tonometricarterial PCO 2 gradients were calculated at baseline and hourly thereafter. H 2 -blockers were not used.
Indirect calorimetry
Whole body carbon dioxide production (V Ç CO 2 ) was measured using continuous indirect calorimetry (Deltatrac, Datex, Helsinki, Finland).
Microdialysis
The microdialysis capillaries used were manufactured in our laboratory. The method has been previously validated for intestinal luminal lactate measurement. 11 The capillary membrane was semipermeable polysulfone with pore size of 60 000 Da. The inner diameter of the capillary lumen was 200 mm and the length of the semipermeable portion was 2.0 cm. The out¯ow tubing was 100 cm long with an inner diameter of 0.134 mm. The in-and out¯ow tubing were inserted inside the tonometer catheter and the microdialysis catheter was ®xed on the surface of the tonometer balloon. The microdialysis catheter was gently compressed to the gut mucosa by ®lling the balloon on the tonometer. The¯ow of the microdialysate (Ringer's acetate) was adjusted to 2 ml min ±1 , and therefore the delay from the tissue to the collecting tubes was 7 min. Tubes were kept on ice during collection. Samples were collected in 30 min fractions throughout the experiment and microdialysate lactate was analysed within 5 min of fraction collection.
Blood¯ow measurement
Flowmeter signals (T206 and T106, Transonic) were recorded (30 Hz) on a computer program for further analysis (Dataq instruments Windaq 1.60, Dataq instruments Inc., Akron, OH, USA). In vivo zero-¯ow was also noted at the end of the experiment (the no-¯ow signal from each vessel after euthanizing the animal) in order to evaluate a possible calibration error developed during the experiment.
Blood samples
Regional blood samples were taken at baseline and at 4, 8, 10, 12 and 14 h. These samples were analysed for haemoglobin (Hemoxymeter OSM3, Radiometer, Copenhagen, Denmark), blood gases (Radiometer, Copenhagen, Denmark), lactate and pyruvate. In addition, samples for IL-1b and IL-6 were taken from the femoral artery. Arterial samples for endotoxin concentration measurements were taken at baseline and after the experiment.
Endotoxin, IL-1b and IL-6 concentrations
Plasma endotoxin concentrations were determined using the Limulus Amebocyte Lysate assay (LAL, Charles RiverEndosafe, Charleston, SC, USA) with chromogenic quantitation (Coatest endotoxin, Chromogenix AB, Mo Èlndal, Sweden). Arterial serum cytokine concentrations (IL-1b and IL-6) were determined with porcine immunoassay for IL-1b and IL-6 (Quantikine P, R&D Systems Inc., Minneapolis, MN, USA).
Lactate and pyruvate measurements
Enzymatic lactate oxidase method with polarographic detection was used for both microdialysate and plasma lactate measurements (YSI 2300 Stat Plus, Yellow Springs Instruments Co. Inc., Yellow Springs, OH, USA). Whole blood pyruvate was measured enzymatically (Sigmas UV-706 kit, Sigma Diagnostics, St Louis, MO, USA) with spectrophotometric detection (Shimadzu CL-750, Shimadzu Corporation, Kyoto, Japan). Pyruvate measurements were performed daily.
Calculations and statistical analysis
Total splanchnic blood¯ow (Q Ç spl) was calculated as the sum of portal venous and hepatic arterial blood¯ows. Statistical analysis was via SPSS 9.0.1 (SPSS Inc., Chicago, IL, USA). The data are presented as median (interquartile range) at baseline, 4 and 14 h or during the hyperdynamic phase before the death of the animal (all animals reached a hyperdynamic hypotensive circulatory state and therefore n=7 at the hyperdynamic phase despite three deaths before 14 h). Accordingly, Friedman's nonparametric analysis of variance for repeated measurements was used for within group comparison. Differences between the groups at baseline were tested using a nonparametric test for independent samples (Kruskal±Wallis test). Post hoc location of a signi®cant difference within group was performed using Wilcoxon's signed rank test. P<0.05 indicated a statistical signi®cance.
Results
Control and dopexamine-treated animals survived the experiment, while three animals died in the ETX group after 8, 10 and 12 h. Arterial endotoxin concentrations increased in both ETX and DOPE groups while blood endotoxin remained low during control conditions (Table 1) . Dopexamine infusion was started at a dose of 1 mg kg ±1 min ±1 and increased to maximal infusion rates ranging from 9 to 17 mg kg ±1 min ±1 . Systemic haemodynamic and respiratory data are shown in Figure 1 . At baseline the groups were comparable except for V Ç CO 2 (P=0.049, Fig. 1 ) and absolute coeliac trunk blood¯ow (which had a tendency towards signi®cant difference between the groups, P=0.08).
Hypodynamic phase
Regional blood¯ows Endotoxin induced a characteristic biphasic shock with a primary hypodynamic phase (after 4 h). Absolute splanchnic blood¯ow decreased (Q Ç spl) in proportion to the systemic blood¯ow reduction (Table 2) . Endotoxin decreased absolute coeliac trunk (Q Ç trunk) and superior mesenteric artery (Q Ç sma) blood¯ows during the hypodynamic phase in proportion to cardiac output.
Dopexamine reversed the primary low cardiac output observed in the hypodynamic phase (Fig. 1) . Dopexamine prevented the reduction in absolute Q Ç spl while the proportion of splanchnic blood¯ow from cardiac output decreased (Table 2) . Dopexamine appeared to maintain absolute Q Ç trunk, however trunk blood¯ow decreased in four of the seven animals while an increase was observed in three. The proportion of Q Ç trunk from cardiac output decreased. Dopexamine reversed the reduction of absolute Q Ç sma with a minor reduction in proportion to cardiac output (Table 2) .
Regional metabolism Endotoxin was associated with increasing mucosal to arterial PCO 2 gradient only in the colon during the hypodynamic phase and there was no luminal lactate release during the hypodynamic phase at any of the three locations monitored (Table 3) . Arterial hyperlactataemia with moderately elevated arterial lactate±pyruvate ratio (L/P) developed during endotoxin infusion. Veno-arterial lactate gradients became negative and regional venous L/P ratios increased over the stomach and jejunum. Hepatic lactate turnover remained constant.
Dopexamine infusion was associated with marked arterial hyperlactataemia with increasing systemic L/P ratio ( Table 4 ) and decreasing mucosal to arterial PCO 2 gradient in the jejunum (Table 3) . Negative veno-arterial lactate gradients occurred over the stomach, jejunum and colon with increased L/P ratios in the stomach and jejunum, but not the colon. Hepatic lactate turnover remained constant.
Normo/hyperdynamic, hypotensive phase Regional blood¯ows Prolonged endotoxaemia was associated with cardiac output exceeding the baseline level during the hypotensive phase of shock (Fig. 1) . Q Ç spl was maintained at baseline in proportion to cardiac output. The absolute Q Ç sma in addition to its proportion from cardiac output increased. Q Ç trunk and its proportion from cardiac output remained constant during prolonged endotoxaemia (Table 2) .
Dopexamine did not affect absolute or proportional splanchnic blood¯ow compared with baseline. Dopexamine increased the absolute Q Ç sma and its proportion from cardiac output, while the absolute Q Ç trunk was maintained at baseline and its proportion from cardiac output decreased (Table 2) .
Regional metabolism
Prolonged endotoxaemia was associated with increasing mucosal to arterial PCO 2 gradients and luminal lactate release in the stomach and colon. Persistent arterial hyperlactataemia with high L/P ratio was observed during prolonged endotoxaemia. Gastric and mesenteric venoarterial lactate gradients became positive. Gastric and mesenteric venous L/P ratios continued to increase.
Dopexamine reversed high colonic mucosal to arterial PCO 2 gradient and luminal lactate release while it augmented the PCO 2 gradient in stomach. No effect on gastric luminal lactate release was observed. Dopexamine did not reverse arterial hyperlactataemia or high arterial L/P ratio. Gastric veno-arterial lactate gradient and L/P ratio exceeded baseline in dopexamine treated animals while veno-arterial lactate gradients over the jejunum and colon remained at baseline (Table 4) . Heterogeneous effects of dopexamine within splanchnic bed Systemic arterial blood IL-1 and IL-6 concentrations increased after endotoxin challenge and dopexamine did not modify this cytokine response (Table 1) .
Discussion
One of the main ®ndings of the present study was that despite increasing cardiac output at the onset of hypodynamic endotoxin shock, dopexamine decreased the proportional splanchnic blood¯ow. Second, during prolonged endotoxaemia, dopexamine decreased proportional coeliac trunk blood¯ow while it gradually increased the proportional superior mesenteric arterial blood¯ow. Third, during prolonged endotoxaemia both colonic and gastric mucosal to arterial PCO 2 gradients increased and intestinal luminal lactate release occurred suggesting probable mucosal dysoxia. Dopexamine reversed mucosal carbon dioxide stagnation and luminal lactate release in the colon while mucosal to arterial PCO 2 gradient increased further and luminal lactate release persisted in the stomach. Understandably, as this was an experimental porcine model of endotoxin shock with a comparably low number of animals, interpretation of the ®ndings and extrapolation of the data to clinical setting must be made with caution. However, the controlled randomized design with stable control conditions (except for gradually increasing coeliac trunk blood¯ow in control animals) suggest that these ®ndings may be of signi®cance. Moreover they offer further explanation for earlier controversial ®ndings regarding splanchnic perfusion and metabolism during endotoxaemia especially if dopexamine is used as an inotrope.
Dopexamine is widely used in critical illness. One of the main indications for its use is to increase gut perfusion (81% of the intensive care units in UK 1 ). Indeed, dopexamine was primarily considered to selectively increase splanchnic perfusion but controversial results were reported by us in postoperative 2 and by Meier-Hellmann and colleagues 3 in septic patients. In these studies increasing overall splanchnic blood¯ow was associated with decreasing gastric mucosal pH or increasing mucosal to arterial PCO 2 gradient. In addition, if septic patients are treated with norepinephrine, dopexamine does not necessarily increase total splanchnic blood¯ow as reported by Kiefer and colleagues. 4 At least two reasons may explain the controversy. First, the effect of dopexamine on overall splanchnic blood ow may vary with the phase of shock. This was apparent in the present study, where at the onset of the hypodynamic phase the proportion of total splanchnic blood¯ow decreases during dopexamine infusion. After prolonged Table 2 Absolute and proportional regional blood¯ows in endotoxin shock (ETX, n=7), in endotoxin shock treated with dopexamine (DOPE, n=7) and controls (n=7). Q Ç splanchnic/CO, fraction of total splanchnic blood¯ow from cardiac output; SMA/CO, fraction of superior mesenteric blood¯ow from cardiac output; trunk/CO, proportion of coeliac trunk blood¯ow from cardiac output. Data are median (interquartile range) Heterogeneous effects of dopexamine within splanchnic bed endotoxaemia, total splanchnic blood¯ow returns to baseline during dopexamine infusion. Second, the effect of dopexamine on resistance vessels downstream of each arterial branch supplying the viscera may vary. Indeed, during prolonged endotoxaemia dopexamine maintained overall splanchnic blood¯ow at baseline levels while there was a redistribution of blood¯ow within the splanchnic bed. Coeliac trunk blood¯ow decreased but superior mesenteric blood¯ow increased. Clearly, endotoxin infusion per se induced gradual redistribution of blood¯ow within the splanchnic region and this was augmented by dopexamine. This is in accordance with a previous study on endotoxaemic sheep by Schiffer and colleagues. 6 In addition, Schwieger and colleagues 12 showed that endotoxaemia abolishes the vasodilatory effects of two other dopamine-1 receptor agonists, fenoldopam and dopamine in the coeliac trunk. Finally, in other models of systemic in¯ammation such as after extracorporeal circulation in rabbits 13 or pigs, 14 dopexamine appears to have selective vasodilatory effects on vasculature downstream to the superior mesenteric artery as opposed to the coeliac trunk.
We suggest that high metabolic rate during in¯ammation (as indicated by increasing systemic V Ç CO 2 ) was met by increasing oxygen delivery to tissues supplied by the superior mesenteric artery but not the tissues supplied by the coeliac trunk. Thereby, the blood¯ow reduction (relative to metabolic demand) to the gastric mucosa during prolonged endotoxaemia was severe enough to induce not only increasing mucosal to arterial PCO 2 gradient but also luminal lactate release. Dopexamine reversed the increase of mucosal to arterial PCO 2 gradient and luminal lactate release in the colon, while in the stomach dopexamine eventually induced further widening of the mucosal arterial PCO 2 gradient and did not reverse luminal lactate release. We 15 16 and others 17 have described intestinal luminal lactate release in experimental endotoxin shock and in septic patients, respectively. In addition, gastric venous to arterial lactate gradient became positive indicating lactate production, while mesenteric and colonic venous to arterial gradients remained negative or low. Collectively, these data may indicate that gastric mucosal epithelial cells undergo anaerobic metabolism during dopexamine infusion while the metabolic derangement was reversed in the colonic mucosa. Alternatively, intestinal luminal lactate release and regional venous lactate production may be related to inactivation of pyruvate dehydrogenase (PDH) by endotoxin, 18 increased pyruvate production, 19 increased Na-KATPase activity 20 or altered pyruvate delivery to tricarboxylic acid cycle in mitochondria as in poly(ADPribose)polymerase (PARP-1) induced cell injury. 21 PARP-1 is activated by lipopolysaccharide. 22 Since in the present experiment none of these were speci®cally tested, the mechanism underlying the increase in luminal lactate release remains speculative. However, it is reasonable to conclude that, to some extent, the metabolic state of the intestinal mucosal epithelial cells was altered during prolonged endotoxaemia. In support of anaerobic metabolism and dysoxia is the concomitant increase in gastric mucosal to arterial PCO 2 gradient.
The systemic in¯ammatory response during endotoxin shock was con®rmed by high arterial IL-1b and IL-6. This was, by and large, the main purpose for measuring cytokines. Conversely, one aspect of the stability of the model was veri®ed by stable cytokine concentrations in the control group. Additionally, we report here that dopexamine did not modify the in¯ammatory response induced by endotoxin. This is in contrast with the results described by Berendes and colleagues. 23 They found that dopexamine inhibited IL-6 release in CABG patients. Moreover, Dhingra and colleagues 5 previously reported inhibition of lung in¯ammation by dopexamine. One possible explanation for the discrepancy is the high degree of in¯ammatory stimulus by endotoxin infusion in the present experiment when compared with the two other studies.
In conclusion and considering that this was a porcine model for endotoxin shock where extrapolation to humans may be limited, we suggest that dopexamine is not associated with selective overall splanchnic vasodilation in the hypodynamic phase of endotoxin shock. In contrast, dopexamine induces a superselective mucosal perfusion defect in the stomach while colonic mucosal perfusion/ metabolism is ameliorated by dopexamine during prolonged endotoxaemia. In other words, dopexamine induces blood ow redistribution within the splanchnic area, which may not be considered as a homogeneous entity in different disease states or with various drug interventions.
